BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu J, Li H, Sui Y, Du J. Current status and future perspective of radiopharmaceuticals in China. Eur J Nucl Med Mol Imaging 2021. [PMID: 34767047 DOI: 10.1007/s00259-021-05615-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Zheng S. Feasibility Study to Byproduce Medical Radioisotopes in a Fusion Reactor. Molecules 2023;28. [PMID: 36903286 DOI: 10.3390/molecules28052040] [Reference Citation Analysis]
2 Wang T, Lv S, Mou Z, Zhang Z, Dong T, Li Z. Isotope Exchange-Based (18)F-Labeling Methods. Bioconjug Chem 2023;34:140-61. [PMID: 36594786 DOI: 10.1021/acs.bioconjchem.2c00530] [Reference Citation Analysis]
3 Jiang Y, Fang S, Feng J, Ruan Q, Zhang J. Synthesis and Bioevaluation of Novel Technetium-99m-Labeled Complexes with Norfloxacin HYNIC Derivatives for Bacterial Infection Imaging. Mol Pharm 2023;20:630-40. [PMID: 36398935 DOI: 10.1021/acs.molpharmaceut.2c00830] [Reference Citation Analysis]
4 Cui X, Liu Y, Wang C, Wen Z, Li Y, Tang H, Diwu J, Yang Y, Cui M, Liu Z. China’s radiopharmaceuticals on expressway: 2014–2021. Radiochimica Acta 2022;0. [DOI: 10.1515/ract-2021-1137] [Reference Citation Analysis]